KeyBanc reiterates Overweight for Elanco Animal Health stock

Published on 10/05/2026 at 19:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

KeyBanc keeps a USD 30.00 target for Elanco. Elanco Animal Health stock costs EUR 20.20 on October 5, 2026 after EUR 19.67, plus 2.69 percent.

ELAN, US28414H1032, Illustration mit AI erstellt.

Elanco Animal Health (ISIN US28414H1032) was trading at EUR 20.20 at Lang & Schwarz on October 5, 2026 at 7:19 p.m. CEST, up EUR 0.53 or 2.69 percent versus the prior close of EUR 19.67. KeyBanc reiterated its Overweight rating and USD 30.00 price target on September 30, 2026, according to Investing.com.

KeyBanc sees clinic demand

KeyBanc based its view on a mid-September survey of 50 US veterinary clinics. The survey found that 64.00 percent of clinics were prescribing more broad-spectrum parasiticides than a year earlier, while Elanco products Quattro and Zenrelia showed adoption momentum.

The analyst view gives the stock a clear comparison point: the USD 30.00 target stands above the current NYSE quotation of USD 22.61. The primary-exchange figure was last recorded at 1:21 p.m. EDT on October 5, 2026, while the euro quote reflects the later Lang & Schwarz session.

Second-quarter revenue beat estimates

Elanco reported USD 1.37 billion of revenue in the second quarter of 2026, compared with the USD 1.31 billion consensus estimate, and revenue increased 10.20 percent year over year, according to MarketBeat. Adjusted earnings per share came in at USD 0.34, above the USD 0.27 consensus.

For the third quarter of 2026, Elanco guided to adjusted earnings per share of USD 0.19-0.22. Its full-year 2026 adjusted earnings per share outlook stands at USD 1.10-1.16, placing the upcoming report at the center of the next valuation test.

Next report arrives November 6

Elanco's investor-relations calendar schedules the third-quarter 2026 earnings call for November 6, 2026 at 8:00 a.m. EST, according to Elanco. The company operates in animal health, supplying products for companion animals and livestock, so the report will show whether recent parasiticide adoption is translating into broader revenue growth.

After-hours quote and valuation

At Lang & Schwarz, Elanco stock was trading at EUR 20.20 on October 5, 2026 at 7:19 p.m. CEST, plus 2.69 percent versus the prior close of EUR 19.67 on October 2, 2026. On the NYSE, the stock was last at USD 22.61 on October 5, 2026 at 1:21 p.m. EDT; its market capitalization was USD 11.3 billion and its 52-week range was USD 19.40 to USD 27.98.